Camillo Ricordi
University of Miami
870 Papers
9K Citations
Camillo Ricordi is an academic researcher from University of Miami. The author has contributed to research in topics: Transplantation & Islet. The author has an hindex of 94, co-authored 845 publications. Previous affiliations of Camillo Ricordi include University of British Columbia & University of Padua.
Chat about Author
Papers
Effects of ketamine sedation on glucose clearance, insulin secretion and counterregulatory hormone production in baboons (Papio hamadryas).
R. Lehmann,Joseph L. Wagner,L. Fernandez,L. Fernandez,Jacques J. Bourgoignie,Camillo Ricordi,Camillo Ricordi,R. Alejandro,R. Alejandro,Norma S. Kenyon +9 more
TL;DR: Papio hamadryas appears to be a promising pre‐clinical model for the study of endocrine replacement therapy in insulin‐dependent diabetes, however, the data obtained must be interpreted with the knowledge that the anesthetic employed to allow for testing of the animals does have an effect on the parameters described in this report.
Immune tolerance induction by integrating innate and adaptive immune regulators
TL;DR: Understanding the interplays among Treg cells, innate suppressors, and pathogenic effector T (Teff) cells will be critical in the future to assist in the development of therapeutic strategies to enhance and synergize physiological immunosuppressive elements in the innate and adaptive immune system.
Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation.
Alessia Fornoni,Antonello Pileggi,R. D. Molano,Nahir Y. Sanabria,Thor Tejada,Jorge Gonzalez-Quintana,Hirohito Ichii,Luca Inverardi,Camillo Ricordi,Ricardo L. Pastori +9 more
TL;DR: It is demonstrated that targeting JNK in human pancreatic islets results in improved functional beta cell mass and in the regulation of AKT/GSK3B activity.
Prolonged allogeneic islet graft survival by protoporphyrins.
Antonello Pileggi,R. Damaris Molano,Thierry Berney,Hirohito Ichii,Sergio San Jose,E. Zahr,Raffaella Poggioli,E. Linetsky,Camillo Ricordi,Luca Inverardi +9 more
TL;DR: This study tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein hemeoxygenase 1 (HO-1), on allogeneic islet graft survival and the induction of donor-specific hyporesponsiveness in a proportion of the protoborphyrintreated animals.
Islets Transplantation at a Crossroads - Need for Urgent Regulatory Update in the United States: Perspective Presented During the Scientific Sessions 2021 at the American Diabetes Association Congress
Piotr Witkowski,Louis H. Philipson,John B. Buse,R. Paul Robertson,Rodolfo Alejandro,Melena D. Bellin,Fouad Kandeel,David A. Baidal,Jason L. Gaglia,Andrew M. Posselt,Roi Anteby,Piotr J. Bachul,Y. Al-salmay,Kumar Jayant,Angelica Perez-Gutierrez,Rolf N. Barth,John J. Fung,Camillo Ricordi +17 more
TL;DR: Inclusion of islets into the existing regulatory framework for organs for transplantation, along with continued FDA oversight for islet processing, as it is for other cell/tissue products exempt from BLA is proposed.